Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas. Read more about Spectroscopic imaging of D-2-hydroxyglutarate and other metabolites in pre-surgical patients with IDH-mutant lower-grade gliomas.
Decision making and surgical modality selection in glioblastoma patients: an international multicenter survey. Read more about Decision making and surgical modality selection in glioblastoma patients: an international multicenter survey.
Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma. Read more about Identification of magnetic resonance imaging features for the prediction of molecular profiles of newly diagnosed glioblastoma.
A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma. Read more about A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma.
Relationship between 7T MR-angiography features of vascular injury and cognitive decline in young brain tumor patients treated with radiation therapy. Read more about Relationship between 7T MR-angiography features of vascular injury and cognitive decline in young brain tumor patients treated with radiation therapy.
Introduction to special issue dedicated to the 35th anniversary of the joint section on tumors. Read more about Introduction to special issue dedicated to the 35th anniversary of the joint section on tumors.
Convection-enhanced drug delivery for glioblastoma: a review. Read more about Convection-enhanced drug delivery for glioblastoma: a review.
Beyond guidelines: analysis of current practice patterns of AANS/CNS tumor neurosurgeons. Read more about Beyond guidelines: analysis of current practice patterns of AANS/CNS tumor neurosurgeons.
Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies. Read more about Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies.
